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Abstract 
Optically pure C1 and C2–symmetric bidentate N,N and N,P ligands are accessible from (+)-camphor in 
good yields (60-90%). Modified syntheses of precursors 1 and 2 are disclosed as well as the crystal 
structures of three hydroxy-pyrazoline intermediates. Ligands 3, 4, 6, and 11 were fully characterized 
including an X-ray crystal structure of C2-symmetric 6 showing an E configuration in the solid state. 
These ligands form complexes with Ni(II), Pd(II), and Rh(I) in good yields (84-96%), and the X-ray 
crystal structures of complexes 12, 14, and 16 confirm bidentate coordination modes of ligands 4, 6, 
and 11 and distorted tetrahedral (for Ni(II)) and square planar (for Rh(I)) coordination geometries. 
Furthermore, the structure of the Rh(I) complex 16 revealed the presence of a PPh2Cl ligand, which, 
along with spectroscopic data, is proof of an almost quantitative P–N bond cleavage upon coordination 
of ligand 11 to [RhCl(COD)]2. 
 
Keywords: Camphopyrazole; Chiral N,N- and N,P-ligands; 3-hydroxypyrazolines; Ni(II)-, Pd(II)-, and 
Rh(I) complexes; P–N activation; (+)-camphor; hydroxy-pyrazolines 
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1. Introduction 
The design and synthesis of new chiral ligands and complexes play an important role in the 
development of asymmetric catalysis. For over three decades, camphor has been used as an easily 
modifyable and inexpensive building block from the chiral pool for the synthesis of C1, C2, and C3 
symmetric ligands.1 In particular, the campho[2,3-c]pyrazole motif 2 was introduced in the 1980s by 
Steel and co-workers as a new design element for chiral N-donor ligands,3 and more recently, Trapp et 
al. prepared bipyrazole-camphor derived C2-symmetric ligands for Pd-catalyzed Wacker oxidations 
and alkene isomerizations.4 In contrast, camphor-derived P,N ligands5 are less common even though 
chiral P,N ligands such as QUINAP6 are widely used in asymmetric catalysis.7 The success of such 
ligands in asymmetric catalysis is in part due to the hemilability of the N function and in part to the 
synergism between the soft, π-accepting P donor that stabilizes low-valent metal centers, and the hard 
N σ-donor that renders the metal more susceptible to oxidative addition reactions. This combination 
not only stabilizes intermediate oxidation states during a catalytic cycle, but the electronic dissymmetry 
also provides stereocontrol due to distinguishing trans influences of the P and N donors. 
 
Chart 1. Selected examples of camphor-derived N–N and N–P ligands 
N
N
N
N
R
R
N N
N
N
N
NN
O
Burzlaff, 2007
Steel, 1983
Trapp, 2011
N
PPh2
Hiroi, 1999
Kadyrov, 2011
N
N
PCy2O
PPh2
N
Knochel, 2003
 
 
Herein we report the syntheses of new camphopyrazole–based N,N ligands with C1 and C2 symmetry 
and a P-N ligand that resembles QUINAP electronically and in its bite angle. Along these multi–step 
syntheses several intermediates are characterized fully for the first time. We show that the new ligands 
	   3	  
form bidentate coordination compounds with Ni(II), Pd(II), and Rh(I), affording chiral complexes with 
catalytic potential.8 We also disclose a mild and selective P–N bond activation that takes place upon 
coordination of the P,N ligand 11 to a Rh(I) chloride precursor. 
 
2. Syntheses and structures of intermediates and ligands 
Ligands 3, 4, 6, and 11 were prepared starting from (+)-camphor according to Scheme 1. Compound 19 
was obtained in good yield by a modified procedure that minimized the formation of by-products.10 
The X-ray crystal structure of 1 is depicted in Figure 1 and shows the two molecules of the asymmetric 
unit, which are linked via non-centrosymmetric hydrogen bonds between carboxylic acid groups. While 
the carboxyic acid functions are approximately co-planar with the pyrazole rings, the phenyl rings are 
not: The N1–N2–C5–C10 and N3–N4–C23–C24 torsion angles are –47.8(7)° and 36.6(7)°, 
respectively.  
The acyl chloride 2 was obtained in good yield by refluxing 1 in SOCl2 and recrystallizing the crude 
product from heptane,11 and ligand 3 was obtained in acceptable yield by reacting the corresponding 
pyrazole with 2 in the presence of NEt3. For ligand 4, in contrast, it was necessary to first generate the 
sodium-3,5-di-tert-butyl-pyrazolate anion in situ in order to ensure sufficient reactivity with 2. The 
reaction is favored by the formation of NaCl and yields up to 66% of 4. Characteristic 1H NMR 
resonances of 2, 3 and 4 corresponding to the bridgehead protons are found at 3.21 ppm, 2.90 ppm, and 
2.77 ppm, respectively, and the correpsonding 13C resonances of the carbonyl groups are all similar at 
around 162–163 ppm. A modified procedure allowed us to isolate compound 512 on a 30-gram scale in 
good yields and excellent purity. Our method is characterized by an easier purification step that affords 
a product with a significantly higher and sharper melting point (228–230 ºC vs. 178–186 °C).4 Finally, 
the C2-symmetric ligand 6 was isolated in very good yield after acid-catalyzed condensation of phenyl 
hydrazine with 5 in refluxing ethanol. Its precise molecular structure was determined by a single crystal 
X-ray diffraction analysis. Figure 2 shows the approximate C2 point symmetry and E configuration of 
the free ligand 6, characterized by a N2–C1–C18–N4 torsion angle of 175.5(5)°. The dihedral angles 
between the pyrazole rings and phenyl groups may conveniently be approximated by the N2–N1–C12–
C13 and N4–N3–C30–C31 torsion angles, which are -136.8(5)° and -49.2(7)°, respectively. 
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Scheme 1. Syntheses of  (+)-camphor-based N,N and N,P ligands 3, 4, 6, and 11. 
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(i) Diethyl oxalate, NaH, THF; (ii) KOH, EtOH; (iii) PhNHNH2, H2SO4, EtOH, reflux; (iv) SOCl2, 
reflux; (v) for 3: 3,4,5-trimethylpyrazol, NEt3, acetone; for 4: 3,5-di-tert-butylpyrazol, Na, THF; (vi) 
diethyl oxalate, NaH, THF, reflux; (vii) PhNHNH2, HCl, EtOH, reflux; (iix) PhNHNH2, AcOH, EtOH, 
reflux; (ix) hydrazine hydrate, AcOH, EtOH, reflux; (x) hydrazine sulfate; (xi) HCl (conc), THF; (xii) 1. 
LDA, -28 ºC to RT, 2. PClPh2, THF. 
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Figure 1. ORTEP representation (30% displacement ellipsoids) of both independent molecules of 1 in 
the crystal, showing the non-centrosymmetric, hydrogen-bonded dimer. Most H atoms are omitted. 
Selected bond lengths (Å) and angles (°) are: N1–N2 1.373(5), N2–C5 1.413(6), C1–C2 1.462(7), C1–
O1 1.263(6), C1–O2 1.267(7), N3–N4 1.352(5), N3–C20 1.347(6), N4–C23 1.453(6), C19–O3 
1.284(6), C19–O4 1.251(7), C5–N2–N1 117.2(4), C2–N1–N2 105.0(4), N1–C2–C1 120.3(5), O1–C1–
O2 123.7(5), N3–N4–C23 118.0(4), C20–N3–N4 104.8(4), N3–C20–C19 118.9(5), O3–C19–O4 
122.6(5), N3–N4–C21 111.5(4). 
 
 
Figure 2. ORTEP representation (30% displacement ellipsoids) of 6 in the crystal. H atoms are 
omitted. Selected bond lengths (Å) and angles (°) are: N1–N2 1.379(5), N1–C12 1.427(6), C1–C18 
1.464(6), N3–N4 1.381(5), N4–C18 1.354(6), N1–N2–C1 104.5(4), N2–N1–C12 118.1(4), N3–N4–
C18 103.8(4), N4–N3–C30 118.7(4), N4–C18–C1 119.3(4), N2–C1–C18 118.8(4). 
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The hydrated pyrazole 7 was prepared in almost quantitative yield. Its molecular structure was 
established by single crystal X-ray crystallography and confirms three important features (see Figure 
3): (i) a trans-configuration about C1–C18, which also implies that the camphor moieties are in trans 
positions to each other, (ii) a preference for the diketo tautomer, and (iii) the presence of a hydro-
hydroxy pyrazole ring. The attempted condensation of diketone 7 with hydrazine sulfate only lead to 
the dehydration and tautomerization of 7 affording the keto-enol pyrazole 8. Its crystal structure again 
shows a trans configuration of the C17–C18 bond and the camphor units (Figure 4). Our target 
molecule 10 could not be obtained by condensation of hydrazine with 8 under varying conditions, but 
the condensation of 7 with hydrazine produced 9, which was dehydrated in refluxing THF in the 
presence of HCl to afford 10 in very good yields. The X-ray crystal structure of 9 (Figure 5), which 
crystallized as a hemihydrate, reveals two interesting features: it maintains the hydrated phenyl 
substituted pyrazole ring, and the presence of the second H-substituted pyrazole ring forces a cis-
configuration of the molecule, probably thanks to the H-bonding to N2. Finally, in situ deprotonation 
of 10 with LDA at -28 °C, followed by reaction with PPh2Cl and washing with hexane afforded the P-
N ligand 11 as a white powder in good yield. The 31P NMR spectrum shows a singlet at 45.9 ppm that 
remained unchanged after heating at 45 °C for 2 h.13 The structure of 11 was confirmed in a Rh 
complex (vide infra). 
 
 
 
 
	   7	  
 
Figure 3. ORTEP representation (30% probability ellipsoids) of one of the two independent molecules 
of 7 in the crystal. Most H atoms are omitted. Selected bond lengths (Å) and angles (°) are: C1–N2 
1.308(4), N1–N2 1.361(4), N1–C12 1.413(4), N1–C3 1.500(4), C3–O1 1.394(4), C18–O2 1.235(4), 
C24–O3 1.210(4), C18–C19 1.501(5), C1–N2–N1 109.4(3); N2–N1–C12 117.3(3);  N2–C1–C2 
113.6(3); O2–C18–C1 120.3(3); O2–C18–C19 122.6(3), C18–C1–C2 127.5(3), O1–C3–N1 110.0(3),  
O3–C24–C19 125.5(3). 
 
 
Figure 4. ORTEP representation (50% probability ellipsoids) of one of the two independent molecules 
of 8 in the crystal. Most H atoms are omitted. Selected bond lengths (Å) and angles (°) are: O1–C18 
1.353(3), O2–C20 1.243(3), N1–C17 1.344(3), N1–N2 1.368(3), N2–C1 1.362(3), N2–C11 1.422(3), 
C1–C2 1.358(3), C2–C17 1.394(3), C17–C18 1.465(3), C18—C19 1.350(3), C19–C20 1.454(3), N2–
C1–C6 143.1(2), C17–C2–C3 146.7(2), O1–C18–C17 111.6(2). 
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Figure 5. ORTEP representation (50% probability ellipsoids) of one of the two independent molecules 
of 9 in the crystal. Most H atoms are omitted. Selected bond lengths (Å) and angles (°) are: C1–C5 
1.489(2), N2–C1 1.292(2), N2–N3 1.373(2), N3–C4 1.482(2), C4–C5 1.570(2), O12–C4 1.405(2), C1–
C21 1.451(2), N22–C21 1.371(2), N22–N23 1.357(2), N23–C24 1.323(2), C24–C25 1.394(2), C21–
C25 1.377(2), O12–C4–N3 110.4(1), O12–C4–C5 114.9(1), C1–C5–C4 102.2(1). 
 
3. Complexes of Nickel, Palladium, and Rhodium 
Ligands 3, 4 and 6 were then reacted with NiBr2(THF)2 14 in THF solution at room temperature to 
afford complexes 12, 13 and 14, respectively, in very good isolated yields (Scheme 2). These 
complexes are air-stable for a few hours and display low solubilities in hydrocarbon solvents. Although 
the paramagnetic nature of complexes 12–14, precluded a meaningful NMR characterization, elemental 
analyses are satisfactory, and single crystal X-ray diffraction analyses of 12 and 14 confirm their 
structures. Complex 15 was obtained from PdCl2(CH3CN)215 and ligand 6 in THF solution. The 
complex is air-stable and highly soluble in common organic solvents. The 1H NMR spectrum shows a 
slight but characteristic low frequency shift of 0.05 ppm of the bridge-head protons when compared to 
the free ligand. 
One of the two symmetry independent molecules of 12 is depicted in Figure 4. In both of them the 
tetrahedral coordination geometry is distorted as a result of the small bite angle of the ligand of around 
90°, which is compensated by an increase of the Br–Ni–Br angles to about 125°. In both molecules, the 
ligand is coordinated to the nickel atom through the available N atoms forming a six-membered planar 
chelation ring. The Ni–N and Ni–Br bond distances in 12 are slightly shorter than the ones observed in 
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similar nickel complexes with six-membered chelate rings.16,17 The dihedral angles between the 
pyrazole rings and phenyl groups may be conveniently approximated by the N1–N2–C13–C14 and 
N7–N8–C36–C37 torsion angles, which are 66.6(13)° and -65.8(9)°, respectively. 
 
Chart 2. The Ni(II) and Pd(II) complexes 12–15  
12; R1, R2, R3 = Me; 84%
13; R1, R3 = t-Bu, R2 = H; 96%
N
N
N
N
Ph
Ph
MX2
14; M = Ni, X = Br; 85%
15; M = Pd, X = Cl; 82%
N
N
O
N
Ph
N
R3
R2
R1
Ni
Br
Br
  
 
 
 
Figure 4. ORTEP view (30% displacement ellipsoids) of one of the two independent molecules of 12 
in the crystal. H atoms are omitted. Selected bond lengths (Å) and angles (°) are: N1–Ni1 1.968(10), 
N3–Ni1 1.979(10), Ni1–Br1 2.348(3), Ni1–Br2 2.358(2), O1–C4 1.204(14), C4–N4 1.383(15), C4–C5 
1.494(14), Br1–Ni1–Br2 125.38(8), N1–Ni1–N3 89.5(4), C5–N1–N2 105.8(8), N4–N3–C1 104.9(10). 
 
Complex 14 also crystallized with two independent molecules in the asymmetric unit representing the 
same enantiomer but differing in the orientation of the phenyl rings (Figure 5). One of the bromine 
atoms in each of the independent molecules was disordered to a small extent. Two alternative 
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orientations were refined for each molecule resulting in site occupancies of 0.949(2) and 0.051(2) for 
Br2 and Br2A and of 0.956(2) and 0.044(2) for Br3 and Br3A, respectively. The distorted tetrahedral 
coordination geometry around Ni shows Br–Ni–Br angles of 121°–122° (considering only the major 
occupied sites for the bromide ligands in each independent molecule) and narrow N–Ni–N bite angles 
of around 80°. The five-membered chelation ring, together with the pyrazole rings, form a roughly 
coplanar fused three ring system. The Ni–N bond distances are slightly longer than values found in 
similar nickel dibromide Schiff-base complexes with five–membered chelate rings.14, 16 The N1–C3–
C4–N3 torsion angle of the backbone is 2.5(5)º (6.9(5)º for the other independent molecule). The 
dihedral angles between the planes described by the phenyl groups and pyrazole rings are around 50º 
(see the corresponding torsion angles in the caption to Figure 5; for the second molecule the values are 
41.0(5)º and 54.9(5)º). 
 
 
Figure 5. ORTEP view (50% displacement ellipsoids) of one of the two independent molecules of 14 
in the crystal. H atoms are omitted. Selected bond lengths (Å) and angles (°) are: Ni1–N1 2.015(3), 
Ni1–N3 2.082(3), Ni1–Br1 2.3569(7), Ni1–Br2 2.3468(8), N1–N2 1.367(4), N1–C3 1.372(5), N2–C1 
1.357(5), N3–C4 1.344(5), N3–N4 1.376(4), N4–C6 1.357(5), C1–C2 1.374(5), C2–C3 1.385(5), C3–
C4 1.445(5), C4–C5 1.385(5), C5–C6 1.374(5), N3–Ni1–N1 80.4(1), Br1–Ni1–Br2 120.79(3), N1–
N2–C7–C8 53.7(5), N3–N4–C29–C34 50.2(5). 
 
Finally, two equivalents of ligand 11 were added dropwise to a slurry of [RhCl(COD)]2 (COD = 1,5-
cyclooctadiene) in benzene according to eq 1. After washing the crude product with hexane, an orange 
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powder was isolated in good yield. The 31P NMR spectrum showed two doublets of doublets centered 
at δ = 100.7 ppm (JPRh = 195.0 Hz, JPP' = JP'P = 41.2 Hz) and 130.7 ppm (JPRh = 222.6 Hz, JPP' = JP'P = 
40.2 Hz). This suggested the presence of a Rh center bonded to two different P atoms, and the 
magnitude of the JPP' and JP'P coupling constants pointed at a cis isomer. This unexpected bonding 
situation was then elucidated by an X-ray crystal structure analysis, which revealed the presence of a 
PPh2Cl ligand in complex 16 (Figure 6). The cleavage of the pyrazolylphosphine P–N bond in half of 
the equivalents of ligand 11 by half of the Rh–Cl functions present in the starting material 
[RhCl(COD)]218 accounts for the presence of PPh2Cl in complex 16. Considering this reaction 
stoichiometry, the isolated yield of 16 is 86% based on chloride or phosphorus equivalents.19 
 
N
N
Ph
N
N
P
Rh
Cl
P
Ph Ph Cl
Ph
Ph
2 equiv  11  +  [RhCl(COD)]2 +  other products
C6H6
16, 86% 	   	   (1) 
 
The asymmetric unit contains two independent molecules of 16 having the same ligand chirality. The 
compound crystallized with one molecule of CH2Cl2 per formula unit. Both show distorted square 
planar coordination environments around the Rh atom and are linked by a slipped π-π stacking 
interaction between the phenyl groups attached to atoms P1 and P3. The distance between the centroids 
of the phenyl rings of 4.012(4) Å lies within the values reported for this type of interaction (3.0-4.6 
Å).20 Ligand 11 is indeed bidentate forming a six membered chelate ring in a distorted envelope 
conformation, with Rh being the envelope flap atom: Rh1 is 0.94(5) Å from the mean plane defined by 
atoms P1, N3, C4, C3 and N1 (rms deviation of 0.0352 Å) and Rh2 is 1.04(5) Å from the plane defined 
by atoms N5, C55, C56, N7, and P3 (rms deviation 0.047 Å). This conformation is helped by the fact 
that all N atoms are almost perfectly trigonal planar, while the pseudo tetrahedral P1 atom pushes the 
Rh center out of plane. As anticipated by NMR spectroscopy, the other P ligand is in a cis position and 
turns out to be chlorodiphenylphosphine. The fact that the cis isomer is observed exclusively may be 
rationalized by the above mentioned strongly directing trans-influence exerted by P,N ligands. The 
chlorine atom Cl2 of the PPh2Cl ligand stands roughly anti to the chloride ligand Cl1 with a Cl1–Rh1–
P2–Cl2 torsion angle of -159.03(5)°  (156.81(5)°  for the second molecule). The Rh–N, Rh–P and Rh–
Cl bond lengths lie within expected values.21 The N1-C3-C4-N3 and N5-C55-C56-N7 torsion angles in 
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the bis-pyrazole moieties of the two molecules measure 14.9(5)° and 17.1(4)°, respectively, and are 
much smaller than the value of 65° seen in QUINAP.22 
 
Figure 6. ORTEP view (50% displacement ellipsoids) of both independent molecules of 16 in the 
crystal, showing the slipped intermolecular π-π stacking interaction. H atoms are omitted. Selected 
distances (Å) and angles (º) are: Rh1–N1 2.100(3), Rh1–P1 2.1742(8), Rh1–P2 2.1835(9), Rh1–Cl1 
2.3996(8), P1–N3 1.754(3), N3–C4 1.386(4), C4–C3 1.450(4), C3–N1 1.352(4), P2–Cl2 2.093(1), P1–
N3–C4 128.3(2), N3–C4–C3 125.0(3), N1–C3–C4 121.5(3), Rh1–P1–N3 108.72(9), N1–Rh1–P1 
88.75(8), P2–Rh1–P1 95.93(3), Cl1–Rh1–P2 88.31(3), N1–Rh1–Cl1 89.27(8). 
 
4. Conclusion 
Optically pure (+)-camphor-derived building blocks and C1 and C2-symmetric N,N and N,P ligands are 
readily accessible in gram quantities and good yields. Important intermediates, notably 
hydroxypyrazolines, can also be isolated in good yields. The X-ray crystal structures of the free ligands 
and their Ni(II) complexes confirm the expected coordination modes and geometries. The P,N ligand 
11 proved to possess a reactive P–N bond with respect to [RhCl(COD)]2, which is readily cleaved in 
the presence of the Rh(I)–Cl function. The structural evidence of this reactivity indicates that 
phosphine ligands with pyrazolyl- or imidazolyl-P–N bonds are not compatible with metal-halogenide 
precursors, and that non-halogen counter anions should be employed in order to avoid P–N activation. 
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Complexes 12–16 are being tested as homogeneous catalysts in different organic transformations and 
results will be reported in due course. 
 
5. Experimental 
General considerations: All reactions with air–sensitive compounds were carried out under anaerobic 
and anhydrous conditions, using standard Schlenk and glove box techniques. THF and Et2O were 
distilled under nitrogen from purple Na/Ph2CO solutions; pentane and hexanes from Na2K alloy; 
CH2Cl2 from CaH2. NMR spectra were recorded on a Jeol 400 MHz spectrometer. Optical rotations 
were measured on a Perkin-Elmer 241 polarimeter, and values of c are in g/100mL. Elemental analyses 
were performed at IVIC, samples were handled in air, and hygroscopic compounds are corrected for 
water content. Melting points were measured in sealed capillary tubes and are uncorrected. Commercial 
NaH as 60 % w/w dispersion in mineral oil was used as received. Ethyl formate was dried over CaH2, 
fractionally distilled, and kept over activated MS 4Å. Ethyl camphor-oxalate,23 camphor-oxalic acid,23 
LDA,24 NiBr2(THF)2,14 PdCl2(CH3CN)2,15 and [RhCl(COD)]2 25 were prepared following reported 
procedures. 
 (4S,7R)-7,8,8-trimethyl-4,5,6,7-tetrahydro-4,7-methano-1-phenylindazol-3-carboxylic acid (1): 
Concentrated H2SO4 (1.0 mL) was added slowly to a solution of (+)-camphor-oxalic acid (8.74 g, 38.9 
mmol) in ethanol (50 mL) and the mixture was stirred for 15 min. Then a solution of phenyl-hydrazine 
(6.45 g, 59.6 mmol) in ethanol (30 mL) was added dropwise and the mixture heated to reflux overnight. 
Then the solvent was evaporated and the crude product dissolved in 3.0 M KOH (500 mL). The 
mixture was filtered and the filtrate acidified with 3.0 M HCl to precipitate the product, which was 
filtered off and dried in vacuo. Recrystallization from dichloromethane-hexane (1:1) and HV-drying 
afforded a yellow solid (7.95 g, 70 %). Mp 152-154 ºC. [α]D20 = +72.4 (c 1.021, CHCl3). 1H-NMR (400 
MHz, CDCl3): δ 0.79 (s, 3H), 0.93 (s, 3H), 1.11 (s, 3H), 1.20-1.35 (m, 2H), 1.86-1.89 (m, 1H), 2.13-
2.16 (m, 1H), 3.16-3.17 (d, JH-H = 4 Hz, 1H), 5.43 (s, 1H), 7.35-7.47 (m, 5H). 13C {1H} NMR (101 
MHz, CDCl3): δ 11.98, 19.63, 20.37, 27.20, 33.70, 47.95, 54.04, 63.91, 124.81 (2), 128.62, 128.99 (2), 
133.76, 136.20, 139.39, 155.96, 166.86. Elemental analysis calculated for C18H20N2O2 (%): C, 72.95; H, 
6.80; N, 9.45. Found: C, 72.70; H, 7.12; N, 9.33. X-ray-quality single crystals were obtained by vapor 
diffusion of hexane into a saturated dichloromethane solution of 1 and cooling to -10 °C for 2 d.  
(4S,7R)-7,8,8-trimethyl-4,5,6,7-tetrahydro-4,7-methano-1-phenyl-indazol-3-carbonyl chloride (2): 
1 (1.00 g, 3.37 mmol) was dissolved in SOCl2 (10 mL) and heated under reflux for 3 h. After this time, 
excess SOCl2 was evaporated under vacuum and the residue recrystallized from a dichloromethane-
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hexane mixture (1:5). Drying in vacuo for 4 h afforded 0.90 g (85%) of a beige solid. Mp 140-142 ºC 
(d). [α]D20 = +59.1 (c 0.305, CHCl3). 1H-NMR (400 MHz, CDCl3): δ 0.79 (s, 3H), 0.93 (s, 3H), 1.12 (s, 
3H), 1.25-1.35 (m, 2H), 1.88-1.92 (m, 1H), 2.16-2.19 (m, 1H), 3.21-3.22 (d, JH-H = 4 Hz, 1H), 7.47-
7.55 (m, 5H). 13C {1H} NMR (101 MHz, CDCl3): δ 11.85, 19.56, 20.34, 27.00, 33.60, 48.78, 54.22, 
63.93, 124.85 (2), 129.17 (3), 134.88, 139.09, 139.52, 156.57, 161.98. Elemental analysis calculated 
for C18H19ClN2O⋅H2O (%): C, 64.96; H, 6.36; N, 8.42. Found: C, 64.39; H, 5.88; N, 8.41. 
((4S,7R)-7,8,8-trimethyl-4,5,6,7-tetrahydro-4,7-methano-1-phenyl-indazol-3-yl)(3,4,5-trimethyl-
pyrazol-1yl)methanone (3): A solution of NEt3 (285 mg, 2.81 mmol) in acetone (10 mL) was added to 
a solution of 3,4,5-trimethylpyrazole (310 mg, 2.81 mmol) in acetone (20 mL). The mixture was stirred 
for 15 min and then added to a solution of 2 (886 mg, 2.81 mmol) in acetone (20 mL). After heating to 
reflux for 5 h, the mixture was filtered and the solvent removed under vacuum. The resulting solid was 
washed and slurried in heptane (5x10 mL) and HV-dried to give 665 mg (61%) of a beige powder. Mp 
201-202 ºC. [α]D20 = +46 (c 0.21, THF). 1H-NMR (400 MHz, CDCl3): δ 0.77 (s, 3H), 0.89 (s, 3H), 1.10 
(s, 3H), 1.47-1.49 (m, 1H), 1.59-1.60 (m, 1H), 1.86-1.93 (m, 1H), 1.93 (s, 3H), 2.10-2.19 (m, 1H), 2.19 
(s, 3H), 2.54 (s, 3H), 2.90-2.91 (d, JH-H = 4 Hz, 1H), 7.34-7.52 (m, 5H). 13C {1H} NMR (101 MHz, 
CDCl3): δ 7.75, 12.12, 12.33, 12.51, 19.80, 20.41, 26.89, 34.01, 50.31, 53.73, 63.26, 117.33, 124.89 
(2), 128.24, 128.82 (2), 133.54, 139.03, 139.68, 140.06, 152.13, 154.40, 162.50. Elemental analysis 
calculated for C24H28N4O⋅0.5H2O (%): C, 72.52; H, 7.35; N, 14.09. Found: C, 72.32; H, 7.11; N, 13.92.  
((4S,7R)-7,8,8-trimethyl-4,5,6,7-tetrahydro-4,7-methano-1-phenyl-indazol-3-yl)(3,5-di-tert-butyl-
pyrazol-1yl)methanone (4): Na (0.23 g, 10 mmol) was added to a solution of 3,5-diterbutylpirazole 
(1.05 g, 5.84 mmol) in THF (40 mL) and stirred at RT for 18 h. Then the mixture was filtered and 
added to a solution of 2 (1.50 g, 4.76 mmol) in THF (15 mL) and stirred at RT for 10 h. After 
evaporating the solvent under vacuum, the crude product was dissolved in heptane (30 mL), filtered, 
and the solvent removed under vacuum to afford a beige powder (1.44 g, 66 %). Mp 144-145 ºC. [α]D20 
= +47 (c 0.06, THF). 1H-NMR (400 MHz, CDCl3): δ 0.83 (s, 3H), 0.86 (s, 3H), 1.10 (s, 3H), 1.35 (s, 
9H), 1.30-1.50 (m, 2H), 1.44 (s, 9H), 1.83-1.86 (m, 1H), 2.00-2.06 (m, 1H), 2.76-2.78 (d, JH-H = 4 Hz, 
1H), 6.16-6.17 (s, 1H), 7.39-7.53 (m, 5H). 13C {1H} NMR (101 MHz, CDCl3: δ 12.15, 19.75, 20.44, 
27.72, 30.01 (3), 30.26 (3), 32.45, 33.22, 33.78, 49.22, 53.66, 63.29, 105.85, 124.89 (2), 128.32, 128.82 
(2), 133.61, 139.67, 139.85, 154.31, 157.29, 162.85, 163.00. Elemental analysis calculated for 
C29H38N4O⋅1/2H2O (%): C, 74.48; H, 8.41; N, 11.98. Found: C, 74.14; H, 8.08; N, 11.68. 
	   15	  
 (+)-(1R,1’R)-3,3’-(1,2-Dihydroxyethane-1,2-diylidene)bis[(1,7,7-trimethyl-bicyclo[2,2,1]-heptan-
2-one] (5): A mixture of (+)-camphor (36.5 g, 0.240 mmol) and diethyl oxalate (15.9 g, 0.109 mmol) in 
THF (300 mL) was added to a slurry of NaH (21.5 g, 60% dispersion in mineral oil, 0.54 mmol) in 
THF (100 mL). The mixture was refluxed for 48 h, after which the solvent was removed by rotary 
evaporation. The reaction crude was added to an ice/HCl mixture and extracted with chloroform (3 x 
50 mL). The organic layer was dried with MgSO4, filtered, and stripped to a yellow oil. Slurrying and 
washing with MeOH (3 x 50 mL) yielded 29.09 g (74%) of a yellow powder. Mp 228-230 ºC. [α]D20 = 
+520.8 (c 1.02, CHCl3). Elemental analysis calculated for C22H30O4 (%): C, 73.71; H, 8.43. Found: C, 
73.95; H, 8.76. 1H NMR (400 MHz, CDCl3): δ 0.82 (s, 3H), 0.91 (s, 3H), 0.97 (s, 3H), 1.40-1.46 (m, 
2H), 1.46-1.69 (m, 1H), 1.72-2.04 (m, 1H), 3.26-3.27 (d, JH-H = 4 Hz, 1H), 11.81 (s, 1H) ppm. 13C {1H} 
NMR (101 MHz, CDCl3): δ 8.86, 9.61, 18.65, 18.71, 20.54, 20.72, 26.04, 27.13, 30.53, 31.71, 47.97, 
48.56, 49.00, 49.14, 57.95, 59.65, 120.70, 123.33, 155.34, 157.39, 211.59, 214.79. 
(+)-3,3’-bi(1,1’-diphenyl-pyrazole-camphor) or (1,1’-diphenyl-7,7’,8,8,8’,8’-hexamethyl-
4,4’,5,5’,6,6’,7,7’-octahydro-3,3’-bi-4,7-methano-indazole) (6): HCl (12.0 M, 1.0 mL) was added 
dropwise to a solution of 5 (1.68 g, 4.69 mmol) in ethanol (30 mL). After stirring for 15 min a solution 
of phenyl-hydrazine (1.52 g, 14.0 mmol) in ethanol (20 mL) was added dropwise and the resulting 
mixture refluxed for 24 h. Then, the solvent was removed by filtration and the white solid dried in 
vacuo (1.74 g, 89 %). M.P.: 284-285 ºC (d). [α]D20 = +105.7 (c 1.01, CHCl3). 1H NMR (400 MHz, 
CDCl3): δ 0.85 (s, 3H), 0.94 (s, 3H), 1.16 (s, 3H), 1.32-1.41 (m, 2H), 1.84-1.87 (m, 1H), 2.12-2.15 (m, 
1H), 3.05-3.06 (d, 1H, J = 4 Hz), 7.28-7.30 (t, 1H), 7.39-7.42 (t, 2H), 7.52-7.54 (d, 2H, JH-H = 8 Hz). 
13C {1H} NMR (101 MHz, CDCl3): δ 12.54, 19.93, 20.58, 27.61, 33.92, 48.06, 53.57, 63.34, 124.57 (2), 
127.06, 128.61 (2), 129.08, 139.89, 140.40, 154.11. Elemental analysis calculated for C34H38N4 (%): C, 
81.24; H, 7.62; N, 11.15. Found: C, 81.49; H, 8.02; N, 11.05. Single crystals suitable for an X-ray 
diffraction study were obtained by cooling a saturated EtOH solution of 6 to -10 ° C  for 2 d. 
(+)-3,3’-[(1,2-Dihydroxyethane-1,2-diylidene)(1,7,7-trimethyl-bicyclo[2,2,1]-heptan-2-one)]-(1-
phenyl-camphopyrazo-5-ol) or (+)-3,3’-[(1,2-Dihydroxyethane-1,2-diylidene)(1,7,7-trimethyl-
bicyclo[2,2,1]-heptan-2-one)]-((4’S,7’R)-7’,8’,8’-trimethyl-4’,6’,7’-trihydro-5’-ol-4’,7’-methano-
1’-phenyl-indazol) (7): Acetic acid (0.5 mL) was added dropwise to a solution of 5 (4.50 g, 12.5 
mmol) in EtOH (80.0 mL) and allowed to react for 15 min. Then a solution of phenyl hydrazine (1.36 
g, 12.5 mmol) in EtOH (20.0 mL) was added dropwise to the above mixture and refluxed overnight. 
The solid crude product was isolated by filtration, and recrystallization from methanol at low 
temperature (-10 ºC) followed by HV drying yielded a yellow powder (5.33 g, 95 %). Mp 203-204 ºC. 
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[α]D20 = +228.6 (c 1.01, CHCl3). Elemental analysis calculated for C28H36N2O3·H2O (%): C, 72.07; H, 
8.21; N, 6.00. Found: C, 71.90; H, 8.56; N, 5.67. 1H NMR (400 MHz, CDCl3): δ 0.70 (s, 3H), 0.75 (s, 
3H), 0.85 (s, 3H), 1.08 (s, 3H), 1.12 (s, 3H), 1.19 (s, 3H), 1.12-1.19 (m, 3H), 1.31-1.65 (m, 4H), 1.71-
1.82 (m, 1H), 2.20-2.21 (d, JH-H = 4 Hz, 1H), 2.51 (s, 1H), 3.84-3.85 (d, J = 4 Hz, 1H), 4.26 (s, 1H), 
7.01-7.02 (t, 1H), 7.25-7.27 (t, 2H), 7.54-7.56 (d, J = 8 Hz, 2H) ppm. 13C {1H} NMR (101 MHz, 
CDCl3): δ 9.57, 12.79, 18.91, 19.48, 20.32, 20.83, 22.11, 22.21, 29.38, 31.22, 46.54, 47.06, 48.84, 
51.69, 54.84, 58.26, 59.12, 59.18, 107.35, 118.61 (2), 123.19, 128,71 (2), 142.62, 147.17, 192.13, 
215.55. Single crystals suitable for an X ray analysis were obtained from a cold filtered solution of 7 in 
MeOH (100 mg in 2.0 mL, -10 ºC for two days). 
(+)-(E)-3,3’-(1-phenyl-camphopyrazole-hydroxymethylene)-(1,7,7-trimethylbicyclo[2.2.1]-heptan-
2-one) or (E)-3,3’-((4S,7R)-7,8,8-trimethyl-4,6,7-trihydro-5-ol-4,7-methano-1-phenyl-indazol-
hydroxymethylene)-((+)-1’,7’,7’-trimethylbicyclo[2’.2’.1’]-heptan-2’-one) (8): Hydrazine sulfate 
(600 mg, 4.61 mmol) and 7 (2.06 g, 4.60 mmol) were dissolved in EtOH and the mixture refluxed 
overnight. After this time, the precipitate was separated by filtration and dried in vacuo (1.05 g, 53 %). 
Elemental analysis calculated for C28H34N2O2·0.15H2O (%): C, 77.62; H, 7.98; N, 6.47. Found: C, 
77.49; H, 7.76; N, 6.42. [α]D20 = +252 (c 1.00, CHCl3). 1H NMR (101 MHz, CDCl3): δ 0.82 (s, 3H), 
0.87 (s, 3H), 0.91 (s, 3H), 0.92 (s, 3H), 0.99 (s, 3H), 1.15 (s, 3H), 1.20-1.25 (m, 1H), 1.30-1.35 (m, 
1H), 1.44-1.52 (m, 2H), 1.67-1.72 (m, 1H), 1.81-1.86 (m, 1H), 2.02-2.06 (m, 1H), 2.10-2.15 (m, 1H), 
3.08-3.09 (d, 1H), 3.36-3.37 (d, 1H), 7.33-7.37 (m, 1H), 7.42-7.49 (m, 4H), 12.13 (s, 1H) ppm. 13C 
{1H} NMR (101 MHz, CDCl3): δ = 8.93, 12.45, 18.89, 19.73, 20.43, 20.58, 27.02, 27.42, 31.18, 33.75, 
47.97, 48.59, 49.63, 53.62, 58.07, 63.35, 114.91, 124.22, 127.70, 128,82, 132.16, 140.05, 140.53, 
154.33, 156.57, 213.58. Single crystals suitable for an X-ray analysis were obtained by slow 
evaporation of an Et2O solution of 8. 
(+)-3,3'-(1-phenyl-camphopyrazo-5-ol)-(2H-camphopyrazole) or 3,3'-((4S,7R)-7,8,8-trimethyl-
4,6,7-trihydro-5-ol-4,7-methano-1-phenyl-indazol)-((4’S,7’R)-7’,8’,8’-trimethyl-4’,5’,6’,7’-
tetrahydro-4’,7’-methano-2’H-indazol) (9): AcOH (0.50 mL) was added dropwise to a solution of 7 
(1.85 g, 4.30 mmol) in EtOH (80.0 mL) and allowed to react for 15 min. Then a solution of hydrazine 
hydrate (5.15 g, 160 mmol) in EtOH (20.0 mL) was added dropwise and the resulting mixture was 
refluxed overnight. After this time, the precipitate was separated by filtration and purified by column 
chromatography (Merck G60, CH2Cl2) to afford a white solid (0.95 g, 52%). Mp 204-205 ºC. [α]D20 = 
+215.3 (c 0.538, CHCl3). Elemental analysis calculated for: C28H36N4O⋅½H2O⋅¼CH3OH (%): C, 73.50; 
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H, 8.30; N, 11.93. Found: C, 73.22; H, 7.92; N, 12.14. 1H NMR (400 MHz, CDCl3): δ 0.55 (s, 3H), 
0.80-0.88 (m, 1H), 0.90 (s, 3H), 0.92 (s, 3H), 0.98-1.18 (m, 4H), 1.20 (s, 3H), 1.21 (s, 3H), 1.25 (s, 
3H), 1.28-1.50 (m, 2H), 1.77-1.83 (m, 1H), 1.98-2.03 (m, 1H), 2.03-2.05 (t, 1H), 2.64-2.65 (d, JH-H = 4 
Hz, 1H), 3.43-3.44 (d, JH-H = 4 Hz, 1H), 6.10 (s-ancho, 1H), 6.89-6.93 (t, 1H), 7.28-7.32 (t, 2H), 7.62-
7.65 (d, JH-H = 12 Hz, 2H). 13C {1H} NMR (101 MHz, CDCl3): δ 10.64, 13.33, 19.23, 20.30, 20.65, 
21.18, 22.07, 27.62, 30.95, 33.84, 47.77, 47.96, 50.22, 51.65, 54.97, 61.37, 63.29, 104.56, 116.51, 
120.45, 124.89, 128.46, 128.83, 139.63, 143.41, 166.65. Single crystals suitable for an X-ray analysis 
were obtained by slow diffusion of hexane into a CH2Cl2 solution of 9 at -10 ºC for two days. 
3,3'-((+)-1-phenyl-camphopyrazole)-((+)-2H-camphopyrazole) or 3,3'-((4S,7R)-7,8,8-trimethyl-
4,5,6,7-tetrahydro-4,7-methano-1-phenyl-indazol)-((4’S,7’R)-7’,8’,8’-trimethyl-4’,5’,6’,7’-
tetrahydro-4’,7’-methano-2’H-indazol) (10): Aqueous HCl (12.0 M, 0.50 mL) (0.50 mL) was added 
dropwise to a solution of 9 (2.50 g, 5.62 mmol) in THF (50.0 mL). The mixture was refluxed 
overnight. After this time, the solution was washed with saturated aqueous Na2CO3, the organic layer 
decanted off, dried with MgSO4, filtered, and evaporated to an off-white solid (2.04 g, 85 %). Mp 170-
172 ºC. [α]D20 = +170 (c 0.160, CHCl3). Elemental analysis calculated for: C28H34N4⋅0.5C4H8O⋅2H2O 
(%): C, 72.26; H, 8.49; N, 11.23. Found: C, 71.93; H, 8.15; N, 11.52. 1H NMR (400 MHz, CDCl3): δ 
0.74 (s, 3H), 0.83 (s, 3H), 0.93 (s, 3H), 0.96 (s, 3H), 1.12 (s, 3H), 1.24-1.31 (m, 2H), 1.40 (s, 3H), 1.33-
1.40 (m, 2H), 1.81 (THF), 1.82-1.88 (m, 2H), 2.10-2.18 (m, 2H), 3.07-3.08 (d, JH-H = 4 Hz, 1H), 3.34-
3.35 (d, JH-H = 4 Hz, 1H), 3.71 (THF), 7.33-7.47 (m, 5H), 11.32 (s, 1H). The spectrum indicates the 
presence of ca. 0.5 equiv of THF and 2 equiv of water 13C {1H} NMR (101 MHz, CDCl3): δ 10.62, 
12.13, 19.31, 19.73, 20.40, 20.59, 27.27, 27.40, 33.77, 33.80, 47.86, 47.91, 50.23, 53.54, 61.00, 63.55, 
124.12, 124.48(2), 127.72, 128.04, 128.50, 128.95(2), 136.35, 139.77, 154.94, 167.10. 
(+)-3,3'-(1-phenyl-camphopyrazole)-(2-diphenylphosphine-camphopyrazole) or 3,3'-((4S,7R)-
7,8,8-trimethyl-4,5,6,7-tetrahydro-4,7-methano-1-phenyl-indazol)-((4’S,7’R)-7’,8’,8’-trimethyl-
4’,5’,6’,7’-tetrahydro-4’,7’-methano-2’-diphenylphosphine-indazol) (11): A cooled solution (-28 
°C) of LDA (100.9 mg, 0.9418 mmol) in THF (5 mL) was added dropwise over 15 min. to a cooled 
solution (-28 °C) of 10 (400.8 mg, 0.9395 mmol) in THF (10 mL). The resulting dark yellow solution 
was allowed to warm to RT and was stirred for 2 h. The volatiles were then removed in vacuo to afford 
a beige powder that was redissolved in fresh THF (10 mL) and added dropwise over 10 min to a 
solution of PPh2Cl (207.4 mg, 0.9400 mmol) in THF (3 mL). The resulting pale yellow cloudy solution 
was stirred for 6 h and the evaporated to dryness. The resulting solid was extracted with toluene (10 
mL, GF/B filtration). The clear solution was stripped under vacuum to a yellowish solid, which was 
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washed and slurried with hexane (3 x 10 mL) and HV-dried to afford 500.1 mg (87%) of a white 
powder. [α]D20 = +1.36 (c 0.512, THF). Elemental analysis calculated for C40H43N4P·0.1C7H8) (%): C, 
78.85; H, 7.12; N, 9.04. Found: C, 78.75; H, 7.19; N, 9.00. 31P {1H} RMN (162 MHz, CD2Cl2): δ 45.96 
s (1P). 1H RMN (400 MHz, CD2Cl2): δ 7.31 – 7.64 (m, 15H), 3.05 (d, J = 3.30 Hz, 1H), 2.96 (d, J = 
3.66 Hz, 1H), 2.04 (m, 2H), 1.78 (m, 2H), 2.32 (m, 1H), 2.12 (m, 1H), 1.47 (s, 3H), 1.25 – 1.36 (m, 
1H), 1.15 (s, 3H), 0.93 (s, 3H), 0.91 (s, 3H), 0.83 (s, 3H), 0.82 (s, 3H). The spectrum shows 11 mol% 
of co-crystallized toluene. 13C RMN {1H} (101 MHz, CD2Cl2): δ 163.6 (d, 2JC-P = 18.90 Hz, C), 154.1 
(C), 144.3 (C), 140.5 (d, 3JC-P = 12.15 Hz, 2C), 138.1 (d, 3JC-P = 9.45 Hz, C), 137.5 (d, 3JC-P = 9.45 Hz, 
C), 135.4 (d, 3JC-P = 6.75 Hz, C), 135.2 (d, 3JC-P = 6.75 Hz, C), 133.7 (CH), 133.5 (CH), 132.7 (CH), 
132.5 (CH), 129.8 (CH), 129.5 (CH), 128.7(2CH), 128.3 (CH), 128.2 (2CH), 128.1 (CH), 127.1 (CH), 
124.3(2CH), 62.9 (CH), 62.6 (CH), 53.7 (CH), 53.6 (CH), 48.3 (CH), 48.2 (CH), 33.9 (CH2), 33.8 
(CH2), 27.5 (CH2), 27.2 (CH2), 20.2 (CH3), 20.2 (CH3), 19.6 (CH3), 19.5 (CH3), 12.3 (CH3), 12.2 (CH3).  
General protocol for the preparation of nickel complexes. A 0.1 M solution of ligand in THF was 
added slowly to a stirred 0.1 M suspension of the metal halide solvate in THF and the reaction mixture 
was stirred at room temperature for 18 h. The resulting precipitate was separated from the supernatant 
solution by decantation, washed with several portions of hexane, and dried in vacuo for 4 h. 
[NiBr2(3)] (12): Ligand 3 (325 mg, 0.84 mmol) and NiBr2(THF)2 (296 mg, 0.82 mmol). Recrystallized 
from THF-hexane mixture (1:1). Purple solid (430 mg, 84 %). Elemental analysis calculated for 
C24H28Br2N4NiO (%): C, 47.49; H, 4.65; N, 9.23. Found: C, 47.51; H, 4.65; N, 9.28. X-ray quality 
single crystals of 12 were obtained by slow diffusion of hexane into a saturated solution of 7 in THF 
and cooling to -10 °C for 2 d. 
[NiBr2(4)] (13): Ligand 4 (365 mg, 0.79 mmol) and NiBr2(THF)2 (283 mg, 0.77 mmol). Recrystallized 
from THF-hexane mixture (1:1). Green solid (499 mg, 96 %). Elemental analysis calculated for 
C29H38Br2N4NiO⋅3H2O: C, 47.64; H, 6.07; N, 7.66. Found: C, 47.48; H, 6.37; N, 7.47. 
[NiBr2(6)] (14): Ligand 6 (311 mg, 0.62 mmol) and NiBr2(THF)2 (225 mg, 0.62 mmol). Grey solid 
product (380 mg, 85 %). Elemental analysis calculated for C34H38Br2N4Ni (%): C, 56.62; H, 5.31; N, 
7.77. Found: C, 56.35; H, 5.48; N, 7.53. Slow evaporation at room temperature of a saturated solution 
of 14 in THF afforded crystals suitable for X–ray diffraction. 
[PdCl2(6)] (15): Ligand 6 (250 mg, 0.50 mmol) and PdCl2(CH3CN)2 (129 mg, 0.50 mmol). Orange 
solid product (279 mg, 82 %). Elemental analysis calculated for C34H38Cl2N4Pd⋅2.5H2O (%): C, 56.32; 
H, 5.98; N, 7.73. Found: C, 56.04; H, 5.39; N, 7.45. 1H NMR (400 MHz, CDCl3): δ 0.83 (s, 6H), 0.88 
(s, 6H), 0.94 (s, 6H), 1.25-1.30 (m, 4H), 1.81-1.86 (m, 2H), 2.17-2.22 (m, 2H), 3.00-3.01 (d, JH-H = 4 
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Hz, 2H), 7.38-7.42 (m, 10H). 13C {1H} NMR (101 MHz, CDCl3): δ 11.16, 19.26, 20.34, 27.08, 33.37, 
47.90, 54.42, 63.18, 125.48, 127.19 (2), 128.61 (2), 129.76, 137.24, 139.52, 159.77. 
[RhCl(11)(PPh2Cl)] (16): A benzene (1.5 mL) solution of ligand 2 (101.4 mg, 0.166 mmol) was added 
to a suspension of [RhCl(COD)]2 (40.9 mg, 0.0829 mmol) in benzene (0.5 mL). The resulting dark 
orange solution was stirred for 4 h and then evaporated to dryness to afford a yellow solid. Washing 
with hexane (3 x 5 mL) yielded 69 mg (86%) of a light orange powder. Elemental analysis calculated 
for C52H53N4P2Cl2Rh (%): N 5.78, C 64.40, H 5.51. Found: N 5.82, C 64.61, H 5.76. 31P {1H} NMR 
(162 MHz, C6D6): δ 130.83 (dd, 1J = 223.3 Hz, 2J = 41.7 Hz, 1P) , 100.70 (dd, 1J = 195.0 Hz, 2J = 41.7 
Hz, 1P). 1H NMR (400 MHz, C6D6): δ 7.70 - 8.31 (m, 10H), 7.33 - 7.39 (m, 2H), 7.25 - 7.31 (m , 1H), 
6.81 - 7.12 (m, 12H), 3.01 (d , J = 3.61 Hz , 1H), 2.95 ( d, J = 3.19 Hz, 1H), 1.90 (m , 1H), 1.72 (m , 
1H), 1.60 (m , 1H), 1.38 (m, 1H ), 1.17 - 1.31 (m , 2H), 1.05 (s , 3H), 0.81-0.91 (m , 2H), 0.61-0.80 (m, 
12H), 0.51 (s, 3H). Crystals suitable for X-ray diffraction were obtained by layering hexane (3 mL) 
onto a 10 % w/w filtered solution of 16 in CH2Cl2 (0.5 mL) and cooling to -27 °C for 3 d. 
Crystal structure determinations: The measurements for 1, 6, 7, and 12 were made on a Rigaku 
AFC-7 diffractometer equipped with a Mercury CCD area-detector using graphite-monochromated Mo 
Kα radiation (λ = 0.71073 Å). The intensities were corrected for Lorentz and polarization effects, and 
an absorption correction based on the multi-scan method was applied by using CrystalClear.26 The 
space group was uniquely determined by the systematic absences.  Equivalent reflections were merged. 
The data for compounds 8 and 14 were collected on a Bruker-Nonius KappaCCD area-detector 
diffractometer27 using graphite-monochromated Mo Kα radiation, and data reduction was performed 
with EvalCCD.28 The data for compound 16 were collected on a Bruker Kappa APEX 2 IμS Duo 
diffractometer29 using Mo Kα radiation with QUAZAR focussing Montel optics and APEX229 for data 
reduction. The measurements for compound 9 were conducted on an Oxford Diffraction SuperNova 
area-detector diffractometer using Mo Kα radiation and an Oxford Instruments Cryojet cooler, and data 
reduction was performed with CrysAlisPro.30 All the structures were solved by direct methods using 
SHELXS-9731, SHELXS-201331 or SHELXTL32 and the non-hydrogen atoms were refined 
anisotropically. All refinements were carried out using SHELXL-9731, SHELXL-2033 or SHELXTL32. 
The data collection and refinement parameters are given in Table 1. 
The asymmetric unit of 1 and 7 contains two crystallographic independent molecules of the same 
enantiomer. In compound 1, the acidic protons HO1 and HO3 were located from a difference Fourier 
map, which were included by restrains in the O–H distances. Compound 8 crystallized with two 
independent molecules in the asymmetric unit representing the same enantiomer. H atoms were treated 
	   20	  
as follows: The positions of the two O-bound H atoms H01O1 and H03O3 were taken from a 
difference Fourier synthesis and refined. Structure 12 crystallized with two independent metal 
complexes and two THF molecules in the asymmetric unit. Both solvent molecules were found 
disordered over two sets of positions, which were included by restrains in the C–C and C–O distances 
and complementary occupancies of 63:37 and 57:43, respectively. These atoms were refined 
anisotropically. For structure 14, similarity restraints were applied to the atomic displacement 
parameters during the refinement of the disordered Br atoms. The crystal under study was an inversion 
twin with a major twin fraction of 0.851(7) (see Flack parameter). 
CCDC 1477566–1477573 contain the supplementary crystallographic data for this paper. The data can 
be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/getstructures. 
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Table 1. Crystallographic data for compounds 1, 6–9, 12, 14, and 16 
 1 6 7 8 9 12 14 16 
Empirical formula C36H38N4O4 C34H38N4 C48H10N4O4 C28H34N2O2 C28H37N4O0.5 C24H29Br2N4NiO C34H38Br2N4Ni C53H55Cl4N4P2Rh 
Formula weight 590.70 502.68 706.60 430.57 453.63 608.04 721.21 1054.66 
Crystal System Monoclinic Monoclinic Orthorhombic Triclinic Orthorhombic Triclinic Monoclinic Triclinic 
Space group P21 P21 P212121 P1 P212121 P1 P21 P1 
Temperature (K) 293 293 293 150 100 293 150 100 
a (Å) 12.5256(18) 7.333(5) 11.040(4) 6.7124(3) 13.17868(16) 9.223(5) 10.2647(11) 11.735(2) 
b (Å) 6.9042(10) 19.593(13) 13.819(5) 7.8719(2) 16.2917(2) 13.743(10) 21.107(3) 13.034(2) 
c (Å) 19.193(3) 9.950(7) 17.884(6) 22.1268(9) 24.7251(3) 13.752(9) 14.5382(6) 17.062(2) 
α (º) 90 90 90 91.525(3) 90 113.004(11) 90 75.921(3) 
β (º) 90.170(3) 93.161(19) 90 91.674(4) 90 92.511(12) 92.556(6) 82.045(3) 
γ (º) 90 90 90 91.353(3) 90 103.529(12) 90 77.452(3) 
V(Å3) 1659.8(4) 1427.4(16) 2728.5(15) 1167.90(8) 5308.11(11) 1542.1(17) 3146.7(6) 2460.6(5) 
Z 2 2 3 2 8 2 4 2 
Reflections  
collected/unique 19113/5871 14714/5039 32025/5132 36991/5143 54496/10819 17206/10195 90257/14957 87766/22899 
Reflns observed  
[I > 2σ(I)] 2873 2832 3504 4730 9285 7211 13372 21035 
R(int) 0.072 0.071 0.056 0.045 0.025 0.026 0.050 0.036 
Restraints/parameters 1/397 1/344 0/317 3/595 0/633 3/618 13/772 3/1153 
R(F)  
[I  > 2σ(I) reflns] 0.068 0.080 0.061 0.038 0.036 0.060 0.036 0.028 
wR(F2) (all data) 0.196 0.202 0.190 0.092 0.092 0.204 0.085 0.069 
Goodness-of-fit  
on F2 1.08 1.06 1.15 1.08 1.05 1.20 1.08 1.03 
Max./min. Δρ (e Å−3) 0.20/-0.29 0.18/-0.20 0.23/-0.18 0.20/-0.25 0.25/-0.18 0.67/-0.59 0.49/-0.61 0.46/-0.54 
	  
